MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s40268-026-00551-y

Медицинская библиотека · Drugs in R&D · 2026

Anti-Fungal and Toxicology Assessment of ISFP10, an Inhibitor of Fungal Phosphoglucomutase (PGM).

Pellegrino Madeline R, Bindzus Marc, Kottom Theodore J, Ayyalasomayajula Savita, Achilonu Conrad C, Yi Eunhee S, Limper Andrew H

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND

OBJECTIVE

The novel small molecule ISFP10 inhibits fungal phosphoglucomutase (PGM) activity in Aspergillus fumigatus and Pneumocystis spp. With 50-fold selectivity over the human isoform, conferred by a conserved cysteine residue present in several pathogenic fungi, ISFP10 may represent a promising broad-spectrum antifungal. We evaluated its activity against Candida albicans and Candida glabrata, followed by toxicology assessment in mice.

METHODS

Minimum inhibitory concentration susceptibilities were performed on three strains of C. albicans and C. glabrata and compared with fluconazole. Growth inhibition was further assessed in an 8-h, concentration-dependent growth assay. For toxicology, C57BL6 mice received once-daily intraperitoneal injections of vehicle control (dimethyl sulfoxide) or ISFP10 (10 mg/kg) for 7 days. Body weight, complete blood count (CBC), blood chemistry, histopathology of major organs, and lung extracellular matrix (ECM) and cytokine levels (ELISA, qPCR) were analyzed.

RESULTS

ISFP10 inhibited all tested Candida strains with significantly greater potency than fluconazole. It also showed concentration-dependent inhibition of growth in liquid culture. In mice, no significant differences in daily or final body weight, ECM transcript levels, or interleukin (IL)-6 expression were observed between groups. Tumor necrosis factor-α (TNFα) levels in lung tissue were significantly reduced in ISFP10-treated animals, suggesting a potential anti-inflammatory effect. Blood chemistry and CBC revealed minor abnormalities (increased neutrophils, decreased potassium), but these were not clinically significant. Histopathologic evaluation showed no evidence of organ toxicity.

CONCLUSIONS

ISFP10 demonstrates potent antifungal properties against C. albicans and C. glabrata and a favorable safety profile in vivo, supporting its further development as a potential broad-spectrum antifungal agent.

Для цитирования: Pellegrino Madeline R, Bindzus Marc, Kottom Theodore J, Ayyalasomayajula Savita, Achilonu Conrad C, Yi Eunhee S, Limper Andrew H. Anti-Fungal and Toxicology Assessment of ISFP10, an Inhibitor of Fungal Phosphoglucomutase (PGM).. Drugs in R&D. 2026. DOI: 10.1007/s40268-026-00551-y.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.